News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 25, 2025
·
5 min read
Press Releases
PreveCeutical Announces Date for Annual General and Special Meeting
June 25, 2025
·
2 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
June 24, 2025
·
4 min read
Press Releases
InMed’s INM-901 Significantly Reduces Neuroinflammation in Alzheimer’s Disease Ex Vivo Study
June 24, 2025
·
6 min read
Press Releases
IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones
June 23, 2025
·
1 min read
Press Releases
PlasCred Circular Innovations Inc. Announces Extension of Strategic Private Placement Closing
June 23, 2025
·
1 min read
Press Releases
Medicus Pharma Ltd. Announces Appointment of Andrew Smith as Chief Operating Officer
June 23, 2025
·
1 min read
Press Releases
Moss Genomics Announces Strategic Investment in Genomes.io
June 19, 2025
·
4 min read
Press Releases
Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2025 Conference Call
June 18, 2025
·
3 min read
Press Releases
Telo Genomics Initiate Clinical Trial for Minimal Residual Disease in Multiple Myeloma
June 18, 2025
·
7 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us